Impact of Moderate Altitude on Lung Diseases and Risk of High Altitude Illnesses

被引:1
|
作者
Perez-Padilla, Rogelio [1 ]
机构
[1] Inst Nacl Enfermedades Resp Ismael Cosio Villegas, Dept Res Smoking & Chron Obstruct Pulm Dis, Mexico City, DF, Mexico
来源
REVISTA DE INVESTIGACION CLINICA-CLINICAL AND TRANSLATIONAL INVESTIGATION | 2022年 / 74卷 / 05期
关键词
Moderate altitude; Acute mountain sickness; High altitude pulmonary edema; High altitude cerebral edema; Oxygen therapy; Monge's disease; ACUTE MOUNTAIN-SICKNESS; OBSTRUCTIVE PULMONARY-DISEASE; RESPIRATORY-DISTRESS-SYNDROME; SIMULATED ALTITUDE; POPULATION; MORTALITY; ASTHMA; OXYGEN; SLEEP; EDEMA;
D O I
10.24875/RIC.22000088
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
A large world population resides at moderate altitudes. In the Valley of Mexico (2240 m above sea level) and for patients with respiratory diseases implies more hypoxemia and clinical deterioration, unless supplementary oxygen is prescribed or patients move to sea level. A group of individuals residing at 2500 or more meters above sea level may develop acute or chronic mountain disease but those conditions may develop at moderate altitudes although less frequently and in predisposed individuals. In the valley of Mexico, at 2200 m above sea level, re-entry pulmonary edema has been reported. The frequency of other altituderelated diseases at moderate altitude, described in skiing resorts, remains to be known in visitors to Mexico City and other cities at similar or higher altitudes. Residents of moderate altitudes inhale deeply the city's air with all pollutants and require more often supplementary oxygen. (REV INVEST CLIN. 2022;74(5):232-43)
引用
收藏
页码:232 / 243
页数:12
相关论文
共 50 条
  • [1] The Impact of Moderate-Altitude Staging on Pulmonary Arterial Hemodynamics after Ascent to High Altitude
    Baggish, Aaron L.
    Fulco, Charles S.
    Muza, Stephen
    Rock, Paul B.
    Beidleman, Beth
    Cymerman, Allen
    Yared, Kibar
    Fagenholz, Peter
    Systrom, David
    Wood, Malissa J.
    Weyman, Arthur E.
    Picard, Michael H.
    Harris, N. Stuart
    HIGH ALTITUDE MEDICINE & BIOLOGY, 2010, 11 (02) : 139 - 145
  • [2] High-Altitude Illnesses: Physiology, Risk Factors, Prevention, and Treatment
    Taylor, Andrew T.
    RAMBAM MAIMONIDES MEDICAL JOURNAL, 2011, 2 (01):
  • [3] Illnesses at high altitude
    Schoene, Robert B.
    CHEST, 2008, 134 (02) : 402 - 416
  • [4] Who is susceptible to acute high altitude illnesses?
    Baertsch, Peter
    Dehnet, Cliristoph
    FLUGMEDIZIN TROPENMEDIZIN REISEMEDIZIN, 2018, 25 (02): : 69 - 74
  • [5] Acute altitude illnesses
    Imray, Chris
    Booth, Adam
    Wright, Alex
    Bradwell, Arthur
    BMJ-BRITISH MEDICAL JOURNAL, 2011, 343
  • [6] Altitude illnesses
    Gatterer, Hannes
    Villafuerte, Francisco C.
    Ulrich, Silvia
    Bhandari, Sanjeeb S.
    Keyes, Linda E.
    Burtscher, Martin
    NATURE REVIEWS DISEASE PRIMERS, 2024, 10 (01):
  • [7] Methazolamide in high-altitude illnesses
    Lu, Hui
    Zhang, Huaqun
    Jiang, Yuanying
    EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2020, 148
  • [8] Acute High-Altitude Illnesses
    Scherrer, Urs
    Rexhaj, Emrush
    Rimoldi, Stefano F.
    NEW ENGLAND JOURNAL OF MEDICINE, 2013, 369 (17) : 1665 - 1665
  • [9] Acute High-Altitude Illnesses
    Baertsch, Peter
    Swenson, Erik R.
    NEW ENGLAND JOURNAL OF MEDICINE, 2013, 368 (24) : 2294 - 2302
  • [10] High altitude illness and related diseases - a review
    Gudbjartssont, Tomas
    Sigurdsson, Engilbert
    Gottfredsson, Magnus
    Bjornsson, Olafur Mar
    Gudmundsson, Gunnar
    LAEKNABLADID, 2019, 105 (11): : 499 - 507